Recently, Lin et al. reported a case of 45-year-old man with relapsed HS showing very high PD-L1 expression (90%) who was treated with nivolumab and pembrolizumab and had a PFS exceeding 3 years [101]. The gene discussed is CD274; the disease is histiocytic sarcoma.